Overview

PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians

Status:
Completed
Trial end date:
2019-07-24
Target enrollment:
Participant gender:
Summary
The purpose of conducting this study is to obtain PK data of Beclometasone Dipropionate (BDP)/Beclometasone-17-MonoPropionate (B17MP), Formoterol Fumarate (FF) and Glycopyrronium Bromide (GB) after inhalation of CHF 5993 in Japanese as well as Caucasian healthy subjects under the same setting.
Phase:
Phase 1
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.